Semi-quantitative detection of 33 psychoactive substances from DBS by LC-MS/MS. Screening-level substance detection on a graded scale.
33 substances
3–5 working days
This panel provides semi-quantitative detection of 33 psychoactive substances from a dried blood spot, reported on a graded scale (+/++/+++). Designed for informational screening purposes.
Clinical indications include:
33 substances including amphetamines, benzodiazepines, opioids (morphine, codeine, fentanyl), cocaine and metabolites, MDMA, tramadol, methadone, buprenorphine, and synthetic cannabinoids. Results reported on semi-quantitative +/++/+++ scale.
All 33 substances are detected simultaneously by LC-MS/MS from a single DBS sample. The semi-quantitative grading system provides indication of exposure level without formal forensic quantification.
From enquiry to results in a few simple steps — no clinic visit required.
This test is available to healthcare professionals, wellness brands, clinics, and research institutions worldwide. We currently serve partners in:
Whether you need testing services for your patients, white-label kits for your brand, or method transfer to your own laboratory — get in touch to discuss how we can work together.
Semi-quantitative detection of 33 psychoactive substances from a DBS sample, including opioids, benzodiazepines, stimulants, synthetic cannabinoids, and novel psychoactive substances.
Results are reported on a graded scale rather than exact concentrations. This provides screening-level detection suitable for workplace, clinical, or research applications. Positive results can be confirmed with quantitative testing.
Finger-prick DBS card.
Results are typically delivered within 3 to 5 working days from the time your sample arrives at our laboratory. The analysis is performed by LC-MS/MS.
Yes, DBS-based screening offers a convenient alternative to urine or oral fluid testing, with the added benefit of sample stability and simple postal logistics.
Masdiag's psychoactive substance screening test is available worldwide through our partner network. We currently serve healthcare professionals, wellness brands, and clinics in Europe, the United Kingdom, Asia, Australia, New Zealand, and the United States. Contact us to discuss testing services, white-label kits, or method transfer to your laboratory.
Whether you need testing services, method transfer, or white-label kit development — we'd love to hear from you.